Page last updated: 2024-08-24

gemcitabine and epoetin alfa

gemcitabine has been researched along with epoetin alfa in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giaccone, G; Pinedo, HM; Savonije, JH; Spanier, BW; van Groeningen, CJ1
diZerega, GS; Espinoza, TB; Meeks, CJ; Roda, N; Rodgers, KE1

Trials

1 trial(s) available for gemcitabine and epoetin alfa

ArticleYear
[Decline in the need for blood transfusions in cancer patients due to the use of epoietin alfa during cisplatin based chemotherapy].
    Nederlands tijdschrift voor geneeskunde, 2001, May-05, Volume: 145, Issue:18

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Gemcitabine; Hematinics; Humans; Male; Middle Aged; Neoplasms; Recombinant Proteins; Treatment Outcome

2001

Other Studies

1 other study(ies) available for gemcitabine and epoetin alfa

ArticleYear
Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.
    Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:6

    Topics: Angiotensin I; Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Proliferation; Deoxycytidine; Drug Synergism; Epoetin Alfa; Erythroid Precursor Cells; Erythropoietin; Female; Filgrastim; Gemcitabine; Granulocyte Colony-Stimulating Factor; Hematinics; Megakaryocytes; Mice; Mice, Inbred C57BL; Myeloid Progenitor Cells; Peptide Fragments; Recombinant Proteins; Stem Cells; Time Factors

2013